| AG-METFORMIN (500 MG) | 02494418 | Marketed | Angita Pharma Inc. | Jan 2023 |
| AG-METFORMIN (850 MG) | 02494442 | Marketed | Angita Pharma Inc. | Jan 2023 |
| AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN (500 MG) | 02557711 | Marketed | Angita Pharma Inc. | Jul 2025 |
| AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN (850 MG) | 02557738 | Marketed | Angita Pharma Inc. | Jul 2025 |
| AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN (1000 MG) | 02557746 | Marketed | Angita Pharma Inc. | Jul 2025 |
| APO-DAPAGLIFLOZIN-METFORMIN (850 MG) | 02536153 | Marketed | Apotex Inc. | Dec 2023 |
| APO-DAPAGLIFLOZIN-METFORMIN (1000 MG) | 02536161 | Marketed | Apotex Inc. | Dec 2023 |
| APO-METFORMIN ER (500 MG) | 02305062 | Marketed | Apotex Inc. | Jun 2023 |
| APO-METFORMIN ER (1000 MG) | 02460653 | Marketed | Apotex Inc. | Oct 2017 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (500 MG) | 02509415 | Marketed | Apotex Inc. | Nov 2022 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (850 MG) | 02509423 | Marketed | Apotex Inc. | Nov 2022 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (1000 MG) | 02509431 | Marketed | Apotex Inc. | Nov 2022 |
| APO-SITAGLIPTIN-METFORMIN (500 MG) | 02435772 | Marketed | Apotex Inc. | Jan 2026 |
| APO-SITAGLIPTIN-METFORMIN (850 MG) | 02435780 | Marketed | Apotex Inc. | Jan 2026 |
| APO-SITAGLIPTIN-METFORMIN (1000 MG) | 02435799 | Marketed | Apotex Inc. | Jan 2026 |
| APO-SITAGLIPTIN/METFORMIN XR (500 MG) | 02506270 | Marketed | Apotex Inc. | Nov 2022 |
| APO-SITAGLIPTIN/METFORMIN XR (1000 MG) | 02506289 | Marketed | Apotex Inc. | Nov 2022 |
| APO-SITAGLIPTIN/METFORMIN XR (1000 MG) | 02506297 | Marketed | Apotex Inc. | Nov 2022 |
| AURO-DAPAGLIFLOZIN / METFORMIN (850 MG) | 02533073 | Marketed | Auro Pharma Inc. | May 2023 |
| AURO-DAPAGLIFLOZIN / METFORMIN (1000 MG) | 02533081 | Marketed | Auro Pharma Inc. | May 2023 |
| AURO-METFORMIN (500 MG) | 02438275 | Marketed | Auro Pharma Inc. | Feb 2017 |
| AURO-METFORMIN (850 MG) | 02438283 | Marketed | Auro Pharma Inc. | Feb 2017 |
| AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (500 MG) | 02547805 | Marketed | Auro Pharma Inc. | Jul 2025 |
| AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (850 MG) | 02547813 | Marketed | Auro Pharma Inc. | Jul 2025 |
| AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE (1000 MG) | 02547821 | Marketed | Auro Pharma Inc. | Jul 2025 |
| GLUCOPHAGE (500 MG) | 02099233 | Marketed | Sanofi-Aventis Canada Inc. | Oct 2007 |
| GLUMETZA (500 MG) | 02268493 | Marketed | Bausch Health, Canada Inc. | Dec 2020 |
| GLUMETZA (1000 MG) | 02300451 | Marketed | Bausch Health, Canada Inc. | Dec 2020 |
| INVOKAMET (500 MG) | 02455404 | Marketed | Janssen Inc. | Jun 2016 |
| INVOKAMET (1000 MG) | 02455420 | Marketed | Janssen Inc. | Jun 2016 |
| INVOKAMET (1000 MG) | 02455455 | Marketed | Janssen Inc. | Jun 2016 |
| JAMP METFORMIN (500 MG) | 02380196 | Marketed | JAMP Pharma Corporation | Sep 2019 |
| JAMP METFORMIN (850 MG) | 02380218 | Marketed | JAMP Pharma Corporation | Sep 2019 |
| JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN (500 MG) | 02556189 | Marketed | JAMP Pharma Corporation | Jul 2025 |
| JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN (850 MG) | 02556197 | Marketed | JAMP Pharma Corporation | Jul 2025 |
| JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN (1000 MG) | 02556200 | Marketed | JAMP Pharma Corporation | Jul 2025 |
| JANUMET (500 MG) | 02333856 | Marketed | Merck Canada Inc | Oct 2009 |
| JANUMET (1000 MG) | 02333872 | Marketed | Merck Canada Inc | Oct 2009 |
| JANUMET XR (500 MG) | 02416786 | Marketed | Merck Canada Inc | Jan 2015 |
| JANUMET XR (1000 MG) | 02416794 | Marketed | Merck Canada Inc | Jan 2014 |
| JANUMET XR (1000 MG) | 02416808 | Marketed | Merck Canada Inc | Jan 2015 |
| JENTADUETO (500 MG) | 02403250 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Apr 2013 |
| JENTADUETO (850 MG) | 02403269 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Apr 2013 |
| JENTADUETO (1000 MG) | 02403277 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Apr 2013 |
| KAZANO (500 MG) | 02417219 | Marketed | Takeda Canada Incorporated | Apr 2014 |
| KAZANO (850 MG) | 02417227 | Marketed | Takeda Canada Incorporated | Apr 2014 |
| KAZANO (1000 MG) | 02417235 | Marketed | Takeda Canada Incorporated | Apr 2014 |
| M-METFORMIN (500 MG) | 02547767 | Marketed | Mantra Pharma Inc. | Nov 2024 |
| M-METFORMIN (850 MG) | 02547775 | Marketed | Mantra Pharma Inc. | Nov 2024 |
| M-METFORMIN (1000 MG) | 02548275 | Marketed | Mantra Pharma Inc. | Nov 2024 |
| M-METFORMIN XR (500 MG) | 02551845 | Marketed | Mantra Pharma Inc. | Sep 2025 |
| M-METFORMIN XR (1000 MG) | 02551853 | Marketed | Mantra Pharma Inc. | Sep 2025 |
| MAR-METFORMIN (500 MG) | 02378620 | Marketed | Marcan Pharmaceuticals Inc. | Jun 2023 |
| MAR-METFORMIN (850 MG) | 02378639 | Marketed | Marcan Pharmaceuticals Inc. | Jun 2023 |
| MAR-METFORMIN XR (500 MG) | 02550504 | Marketed | Marcan Pharmaceuticals Inc. | Oct 2024 |
| MAR-METFORMIN XR (1000 MG) | 02550512 | Marketed | Marcan Pharmaceuticals Inc. | Oct 2024 |
| METFORMIN (500 MG) | 02353377 | Marketed | Sanis Health Inc. | May 2019 |
| METFORMIN (850 MG) | 02353385 | Marketed | Sanis Health Inc. | May 2019 |
| METFORMIN (500 MG) | 02385341 | Marketed | Sivem Pharmaceuticals Ulc | May 2026 |
| METFORMIN (850 MG) | 02385368 | Marketed | Sivem Pharmaceuticals Ulc | May 2026 |
| METFORMIN ER (500 MG) | 02558785 | Marketed | Sanis Health Inc. | Jan 2026 |
| METFORMIN ER (1000 MG) | 02558793 | Marketed | Sanis Health Inc. | Dec 2025 |
| METFORMIN TABLETS (500 MG) | 02514486 | Marketed | Granules India Limited | Feb 2022 |
| METFORMIN TABLETS (850 MG) | 02514494 | Marketed | Granules India Limited | Feb 2022 |
| METFORMIN XR (500 MG) | 02567431 | Marketed | JAMP Pharma Corporation | Oct 2026 |
| METFORMIN XR (1000 MG) | 02567458 | Marketed | JAMP Pharma Corporation | Oct 2026 |
| MINT-METFORMIN (500 MG) | 02388766 | Marketed | Mint Pharmaceuticals Inc | Nov 2023 |
| MINT-METFORMIN (850 MG) | 02388774 | Marketed | Mint Pharmaceuticals Inc | Nov 2023 |
| MINT-METFORMIN XR (500 MG) | 02547309 | Marketed | Mint Pharmaceuticals Inc | Oct 2024 |
| MINT-METFORMIN XR (1000 MG) | 02547317 | Marketed | Mint Pharmaceuticals Inc | Oct 2024 |
| NRA-METFORMIN (500 MG) | 02536439 | Marketed | Nora Pharma Inc. | Aug 2023 |
| NRA-METFORMIN (850 MG) | 02536447 | Marketed | Nora Pharma Inc. | Aug 2023 |
| PRO-METFORMIN (850 MG) | 02314894 | Marketed | Pro Doc Limitee | Jul 2025 |
| PRO-METFORMIN (500 MG) | 02314908 | Marketed | Pro Doc Limitee | Jul 2025 |
| PRO-SITAGLIPTIN-METFORMIN (500 MG) | 02552817 | Marketed | Pro Doc Limitee | Apr 2026 |
| PRO-SITAGLIPTIN-METFORMIN (850 MG) | 02552825 | Marketed | Pro Doc Limitee | Jul 2026 |
| PRO-SITAGLIPTIN-METFORMIN (1000 MG) | 02552833 | Marketed | Pro Doc Limitee | Jul 2026 |
| PRZ-METFORMIN (500 MG) | 02531895 | Marketed | Pharmaris Canada Inc. | Apr 2023 |
| PRZ-METFORMIN (850 MG) | 02531909 | Marketed | Pharmaris Canada Inc. | Apr 2023 |
| PRZ-METFORMIN (1000 MG) | 02534673 | Marketed | Pharmaris Canada Inc. | May 2023 |
| PRZ-SITAGLIPTIN-METFORMIN (850 MG) | 02552310 | Marketed | Pharmaris Canada Inc. | Jun 2026 |
| PRZ-SITAGLIPTIN-METFORMIN (1000 MG) | 02552329 | Marketed | Pharmaris Canada Inc. | Jun 2026 |
| REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (500 MG) | 02540118 | Marketed | Dr Reddy's Laboratories Ltd | Oct 2023 |
| REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (850 MG) | 02540126 | Marketed | Dr Reddy's Laboratories Ltd | Oct 2023 |
| REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE (1000 MG) | 02540134 | Marketed | Dr Reddy's Laboratories Ltd | Oct 2023 |
| RIVA-METFORMIN (500 MG) | 02239081 | Marketed | Laboratoire Riva Inc. | Sep 2026 |
| RIVA-METFORMIN (850 MG) | 02242783 | Marketed | Laboratoire Riva Inc. | Sep 2026 |
| SANDOZ METFORMIN FC (500 MG) | 02246820 | Marketed | Sandoz Canada Inc. | Jan 2006 |
| SANDOZ METFORMIN FC (850 MG) | 02246821 | Marketed | Sandoz Canada Inc. | Jan 2006 |
| SANDOZ SITAGLIPTIN-METFORMIN (500 MG) | 02503956 | Marketed | Sandoz Canada Inc. | Jan 2023 |
| SANDOZ SITAGLIPTIN-METFORMIN (850 MG) | 02503964 | Marketed | Sandoz Canada Inc. | Jan 2023 |
| SANDOZ SITAGLIPTIN-METFORMIN (1000 MG) | 02503972 | Marketed | Sandoz Canada Inc. | Jan 2023 |
| SANDOZ SITAGLIPTIN-METFORMIN XR (500 MG) | 02529106 | Marketed | Sandoz Canada Inc. | Mar 2023 |
| SANDOZ SITAGLIPTIN-METFORMIN XR (1000 MG) | 02529114 | Marketed | Sandoz Canada Inc. | Mar 2023 |
| SANDOZ SITAGLIPTIN-METFORMIN XR (1000 MG) | 02529122 | Marketed | Sandoz Canada Inc. | Mar 2023 |
| SITAGLIPTIN-METFORMIN (500 MG) | 02529157 | Marketed | Sivem Pharmaceuticals Ulc | Feb 2023 |
| SITAGLIPTIN-METFORMIN (850 MG) | 02529165 | Marketed | Sivem Pharmaceuticals Ulc | Feb 2023 |
| SITAGLIPTIN-METFORMIN (1000 MG) | 02529173 | Marketed | Sivem Pharmaceuticals Ulc | Feb 2023 |
| SITAGLIPTIN/METFORMIN (500 MG) | 02560445 | Marketed | Sanis Health Inc. | Mar 2026 |
| SITAGLIPTIN/METFORMIN (850 MG) | 02560453 | Marketed | Sanis Health Inc. | Mar 2026 |
| SITAGLIPTIN/METFORMIN (1000 MG) | 02560461 | Marketed | Sanis Health Inc. | Mar 2026 |
| SYNJARDY (500 MG) | 02456575 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Aug 2016 |
| SYNJARDY (850 MG) | 02456583 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Aug 2016 |
| SYNJARDY (1000 MG) | 02456591 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Aug 2016 |
| SYNJARDY (500 MG) | 02456605 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Aug 2016 |
| SYNJARDY (850 MG) | 02456613 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Aug 2016 |
| SYNJARDY (1000 MG) | 02456621 | Marketed | Boehringer Ingelheim (Canada) Ltd. | Aug 2016 |
| TARO-METFORMIN XR (500 MG) | 02552027 | Marketed | Taro Pharmaceuticals Inc | Oct 2025 |
| TARO-METFORMIN XR (1000 MG) | 02565536 | Marketed | Taro Pharmaceuticals Inc | May 2026 |
| TEVA-METFORMIN (500 MG) | 02257726 | Marketed | Teva Canada Limited | Jun 2023 |
| TEVA-METFORMIN (850 MG) | 02257734 | Marketed | Teva Canada Limited | Jun 2023 |
| TEVA-SITAGLIPTIN MALATE / METFORMIN (500 MG) | 02520494 | Marketed | Teva Canada Limited | Sep 2024 |
| TEVA-SITAGLIPTIN MALATE / METFORMIN (850 MG) | 02520508 | Marketed | Teva Canada Limited | Sep 2024 |
| TEVA-SITAGLIPTIN MALATE / METFORMIN (1000 MG) | 02520516 | Marketed | Teva Canada Limited | Sep 2024 |
| XIGDUO (850 MG) | 02449935 | Marketed | Astrazeneca Canada Inc | Feb 2016 |
| XIGDUO (1000 MG) | 02449943 | Marketed | Astrazeneca Canada Inc | Feb 2016 |
| APO-METFORMIN (500 MG) | 02167786 | Dormant | Apotex Inc. | Aug 2021 |
| APO-METFORMIN (850 MG) | 02229785 | Dormant | Apotex Inc. | Aug 2021 |
| BIO-METFORMIN (500 MG) | 02564262 | Approved | Biomed Pharma | Dec 2025 |
| BIO-METFORMIN (850 MG) | 02564270 | Approved | Biomed Pharma | Dec 2025 |
| GLN-METFORMIN XR (1000 MG) | 02572273 | Approved | Glenmark Pharmaceuticals Canada Inc. | Oct 2026 |
| GLUMETZA (SB) (1000 MG) | 02268507 | Approved | Bausch Health, Canada Inc. | Dec 2020 |
| GLYCON (500 MG) | 02229516 | Dormant | Bausch Health, Canada Inc. | Feb 2021 |
| GLYCON (850 MG) | 02239214 | Dormant | Bausch Health, Canada Inc. | Feb 2021 |
| GPC-METFORMIN XR (500 MG) | 02463601 | Approved | Strides Pharma Canada Inc | Mar 2021 |
| GPC-METFORMIN XR (1000 MG) | 02463628 | Approved | Strides Pharma Canada Inc | Mar 2021 |
| IPG-METFORMIN (500 MG) | 02378043 | Approved | Marcan Pharmaceuticals Inc. | Mar 2016 |
| IPG-METFORMIN (850 MG) | 02378051 | Approved | Marcan Pharmaceuticals Inc. | Mar 2016 |
| M-SITAGLIPTIN-METFORMIN (500 MG) | 02570602 | Approved | Mantra Pharma Inc. | Aug 2026 |
| M-SITAGLIPTIN-METFORMIN (850 MG) | 02570610 | Approved | Mantra Pharma Inc. | Aug 2026 |
| M-SITAGLIPTIN-METFORMIN (1000 MG) | 02570629 | Approved | Mantra Pharma Inc. | Aug 2026 |
| METFORMIN (500 MG) | 02162822 | Approved | Apotex Inc. | Mar 2021 |
| METFORMIN (850 MG) | 02229517 | Approved | Apotex Inc. | Mar 2021 |
| METFORMIN (500 MG) | 02378841 | Approved | Marcan Pharmaceuticals Inc. | Feb 2012 |
| METFORMIN (850 MG) | 02378868 | Approved | Marcan Pharmaceuticals Inc. | Feb 2012 |
| METFORMIN TABLETS (500 MG) | 02527650 | Dormant | Apotex Inc. | Mar 2024 |
| METFORMIN TABLETS (850 MG) | 02527669 | Dormant | Apotex Inc. | Mar 2024 |
| METFORMIN TABLETS (500 MG) | 02566907 | Approved | Sanis Health Inc. | Mar 2026 |
| METFORMIN TABLETS (850 MG) | 02566915 | Approved | Sanis Health Inc. | Mar 2026 |
| METFORMIN XR (500 MG) | 02565528 | Approved | Taro Pharmaceuticals Inc | Feb 2026 |
| MINT-SITAGLIPTIN/METFORMIN (500 MG) | 02558874 | Approved | Mint Pharmaceuticals Inc | Jun 2025 |
| MINT-SITAGLIPTIN/METFORMIN (850 MG) | 02558882 | Approved | Mint Pharmaceuticals Inc | Jun 2025 |
| MINT-SITAGLIPTIN/METFORMIN (1000 MG) | 02558890 | Approved | Mint Pharmaceuticals Inc | Jun 2025 |
| NB-SITAGLIPTIN-METFORMIN (500 MG) | 02559633 | Approved | NB Pharma Inc. | Jul 2025 |
| NB-SITAGLIPTIN-METFORMIN (850 MG) | 02559641 | Approved | NB Pharma Inc. | Jul 2025 |
| NB-SITAGLIPTIN-METFORMIN (1000 MG) | 02559668 | Approved | NB Pharma Inc. | Jul 2025 |
| NRA-METFORMIN TABLETS (500 MG) | 02448084 | Approved | Nora Pharma Inc. | Jul 2026 |
| NRA-METFORMIN TABLETS (850 MG) | 02448092 | Approved | Nora Pharma Inc. | Jul 2026 |
| NRA-SITAGLIPTIN/METFORMIN (500 MG) | 02566281 | Approved | Nora Pharma Inc. | Mar 2026 |
| NRA-SITAGLIPTIN/METFORMIN (850 MG) | 02566303 | Approved | Nora Pharma Inc. | Mar 2026 |
| NRA-SITAGLIPTIN/METFORMIN (1000 MG) | 02566311 | Approved | Nora Pharma Inc. | Mar 2026 |
| PG-METFORMIN (500 MG) | 02378116 | Approved | Marcan Pharmaceuticals Inc. | Mar 2016 |
| PG-METFORMIN (850 MG) | 02378124 | Approved | Marcan Pharmaceuticals Inc. | Mar 2016 |
| PMS-METFORMIN (850 MG) | 02242589 | Dormant | Pharmascience Inc. | Jul 2024 |
| PMS-METFORMIN - TAB 500MG (500 MG) | 02223562 | Dormant | Pharmascience Inc. | Aug 2025 |
| PMSC-METFORMIN (500 MG) | 02520303 | Dormant | Pharmascience Inc. | Jul 2026 |
| PMSC-METFORMIN (850 MG) | 02520311 | Dormant | Pharmascience Inc. | Jul 2026 |
| PRZ-SITAGLIPTIN-METFORMIN (500 MG) | 02552302 | Approved | Pharmaris Canada Inc. | Oct 2024 |
| RIVA SITAGLIPTIN/METFORMIN (500 MG) | 02545667 | Approved | Laboratoire Riva Inc. | Feb 2024 |
| RIVA SITAGLIPTIN/METFORMIN (1000 MG) | 02545675 | Approved | Laboratoire Riva Inc. | Feb 2024 |
| RIVA-METFORMIN (1000 MG) | 02570254 | Approved | Laboratoire Riva Inc. | Jul 2026 |
| RIVA-SITAGLIPTIN TARTRATE/METFORMIN (850 MG) | 02545705 | Approved | Laboratoire Riva Inc. | Feb 2024 |
| SEPTA-METFORMIN (500 MG) | 02379767 | Dormant | Septa Pharmaceuticals Inc | Jul 2019 |
| SEPTA-METFORMIN (850 MG) | 02379775 | Dormant | Septa Pharmaceuticals Inc | Jul 2019 |
| ACC-METFORMIN (850 MG) | 02409291 | Cancelled Pre Market | Accel Pharma Inc | Dec 2014 |
| ACH-METFORMIN (500 MG) | 02406020 | Cancelled Pre Market | Accord Healthcare Inc | Nov 2024 |
| ACH-METFORMIN (850 MG) | 02406039 | Cancelled Pre Market | Accord Healthcare Inc | Nov 2024 |
| AVA-METFORMIN (500 MG) | 02364506 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVA-METFORMIN (850 MG) | 02364514 | Cancelled Post Market | Avanstra Inc | Aug 2014 |
| AVANDAMET (500 MG) | 02247085 | Cancelled Post Market | Glaxosmithkline Inc | Apr 2013 |
| AVANDAMET (500 MG) | 02247086 | Cancelled Post Market | Glaxosmithkline Inc | Jun 2016 |
| AVANDAMET (500 MG) | 02247087 | Cancelled Post Market | Glaxosmithkline Inc | Apr 2017 |
| AVANDAMET (1000 MG) | 02248440 | Cancelled Post Market | Glaxosmithkline Inc | Jul 2016 |
| AVANDAMET (1000 MG) | 02248441 | Cancelled Post Market | Glaxosmithkline Inc | Mar 2016 |
| BCI METFORMIN (500 MG) | 02265575 | Cancelled Post Market | Baker Cummins Inc | Oct 2006 |
| BCI METFORMIN (850 MG) | 02265583 | Cancelled Post Market | Baker Cummins Inc | Oct 2006 |
| BIO-METFORMIN (500 MG) | 02449323 | Cancelled Pre Market | Biomed Pharma | Jul 2022 |
| BIO-METFORMIN (850 MG) | 02449331 | Cancelled Pre Market | Biomed Pharma | Jul 2022 |
| DOM-METFORMIN (500 MG) | 02229994 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| DOM-METFORMIN (850 MG) | 02242726 | Cancelled Post Market | Dominion Pharmacal | May 2025 |
| ECL-METFORMIN (500 MG) | 02421828 | Cancelled (Unreturned Annual) | Ecl Pharma Group Ltd | Mar 2018 |
| ECL-METFORMIN (850 MG) | 02421836 | Cancelled (Unreturned Annual) | Ecl Pharma Group Ltd | Mar 2018 |
| GLUCOPHAGE (850 MG) | 02162849 | Cancelled Post Market | Sanofi-Aventis Canada Inc. | Jul 2026 |
| GLUCOPHAGE (1000 MG) | 02446065 | Cancelled Pre Market | Sanofi-Aventis Canada Inc. | Jun 2017 |
| INVOKAMET (850 MG) | 02455412 | Cancelled Post Market | Janssen Inc. | Sep 2022 |
| INVOKAMET (500 MG) | 02455439 | Cancelled Post Market | Janssen Inc. | Dec 2024 |
| INVOKAMET (850 MG) | 02455447 | Cancelled Post Market | Janssen Inc. | Sep 2022 |
| INVOKAMET XR (500 MG) | 02477394 | Cancelled Pre Market | Janssen Inc. | Mar 2023 |
| INVOKAMET XR (1000 MG) | 02477408 | Cancelled Pre Market | Janssen Inc. | Mar 2023 |
| INVOKAMET XR (500 MG) | 02477416 | Cancelled Pre Market | Janssen Inc. | Mar 2023 |
| INVOKAMET XR (1000 MG) | 02477424 | Cancelled Pre Market | Janssen Inc. | Mar 2023 |
| JAMP-METFORMIN BLACKBERRY (500 MG) | 02380722 | Cancelled Post Market | JAMP Pharma Corporation | Jul 2019 |
| JAMP-METFORMIN BLACKBERRY (850 MG) | 02380730 | Cancelled Post Market | JAMP Pharma Corporation | Jul 2019 |
| JANUMET (850 MG) | 02333864 | Cancelled Post Market | Merck Canada Inc | Aug 2025 |
| KOMBOGLYZE (500 MG) | 02389169 | Cancelled Post Market | Astrazeneca Canada Inc | Jun 2026 |
| KOMBOGLYZE (850 MG) | 02389177 | Cancelled Post Market | Astrazeneca Canada Inc | Jul 2026 |
| KOMBOGLYZE (1000 MG) | 02389185 | Cancelled Post Market | Astrazeneca Canada Inc | Apr 2026 |
| MED METFORMIN TABLETS 500MG (500 MG) | 02230670 | Cancelled Post Market | Medican Pharma Incorporated | Mar 2011 |
| METFORMIN (500 MG) | 02231389 | Cancelled Post Market | Bdh Inc. | Aug 2000 |
| METFORMIN (500 MG) | 02238827 | Cancelled Pre Market | Laboratoires Confab Inc. | Apr 2021 |
| METFORMIN (850 MG) | 02242793 | Cancelled Post Market | Sorres Pharma Inc | Jun 2014 |
| METFORMIN (500 MG) | 02242794 | Cancelled Post Market | Meliapharm Inc | Jun 2014 |
| METFORMIN (850 MG) | 02246965 | Cancelled Post Market | Meliapharm Inc | Jun 2014 |
| METFORMIN (500 MG) | 02284782 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Oct 2012 |
| METFORMIN (850 MG) | 02284790 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Oct 2012 |
| METFORMIN (500 MG) | 02343606 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| METFORMIN (850 MG) | 02343614 | Cancelled Pre Market | Cobalt Pharmaceuticals Incorporated | Sep 2017 |
| METFORMIN TABLETS 500MG (500 MG) | 02230026 | Cancelled Post Market | Prempharm Inc. | Aug 2005 |
| METFORMIN-500 - TAB 500MG (500 MG) | 02220628 | Cancelled Post Market | Pro Doc Limitee | Jul 2010 |
| METFORMIN-850 (850 MG) | 02231058 | Cancelled Post Market | Pro Doc Limitee | Jul 2010 |
| MYLAN-METFORMIN (500 MG) | 02148765 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2018 |
| MYLAN-METFORMIN (850 MG) | 02229656 | Cancelled Post Market | Mylan Pharmaceuticals Ulc | Jul 2018 |
| NTP-METFORMIN (500 MG) | 02361264 | Cancelled Pre Market | Nt Pharma Canada Ltd | Mar 2017 |
| NTP-METFORMIN (850 MG) | 02361272 | Cancelled Pre Market | Nt Pharma Canada Ltd | Mar 2017 |
| ORB-METFORMIN (500 MG) | 02246613 | Cancelled (Unreturned Annual) | Orbus Pharma Inc. | Apr 2018 |
| ORB-METFORMIN (850 MG) | 02246614 | Cancelled (Unreturned Annual) | Orbus Pharma Inc. | Apr 2018 |
| PHL-METFORMIN (500 MG) | 02246964 | Cancelled Post Market | Pharmel Inc. | Aug 2010 |
| PMS-ROSIGLITAZONE-METFORMIN (500 MG) | 02357887 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PMS-ROSIGLITAZONE-METFORMIN (500 MG) | 02357895 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PMS-ROSIGLITAZONE-METFORMIN (500 MG) | 02357909 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PMS-ROSIGLITAZONE-METFORMIN (1000 MG) | 02357917 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PMS-ROSIGLITAZONE-METFORMIN (1000 MG) | 02357925 | Cancelled Pre Market | Pharmascience Inc. | Aug 2017 |
| PMS-SITAGLIPTIN TARTRATE/METFORMIN (850 MG) | 02535238 | Cancelled Pre Market | Pharmascience Inc. | Jul 2026 |
| PMS-SITAGLIPTIN-METFORMIN (500 MG) | 02532654 | Cancelled Pre Market | Pharmascience Inc. | Jul 2026 |
| PMS-SITAGLIPTIN-METFORMIN (1000 MG) | 02532662 | Cancelled Pre Market | Pharmascience Inc. | Jul 2026 |
| PRIVA-METFORMIN (500 MG) | 02449390 | Cancelled Pre Market | Pharmapar Inc. | Jul 2022 |
| PRIVA-METFORMIN (850 MG) | 02449404 | Cancelled Pre Market | Pharmapar Inc. | Jul 2022 |
| PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (500 MG) | 02534223 | Cancelled Post Market | Pro Doc Limitee | Jul 2026 |
| PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (850 MG) | 02534231 | Cancelled Post Market | Pro Doc Limitee | Jul 2026 |
| PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE (1000 MG) | 02534258 | Cancelled Post Market | Pro Doc Limitee | Jul 2026 |
| Q-METFORMIN (500 MG) | 02339110 | Cancelled Post Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| Q-METFORMIN (850 MG) | 02339129 | Cancelled Post Market | Qd Pharmaceuticals Ulc | Aug 2015 |
| RAN-METFORMIN (500 MG) | 02269031 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| RAN-METFORMIN (850 MG) | 02269058 | Cancelled Post Market | Ranbaxy Pharmaceuticals Canada Inc. | Jul 2025 |
| RATIO-METFORMIN (850 MG) | 02242931 | Cancelled Post Market | Teva Canada Limited | Jul 2021 |
| RATIO-METFORMIN (500 MG) | 02242974 | Cancelled Post Market | Teva Canada Limited | Jul 2021 |
| RHOXAL-METFORMIN (500 MG) | 02233999 | Cancelled Post Market | Rhoxalpharma Inc. | Nov 2009 |
| SANDOZ METFORMIN XR (500 MG) | 02479575 | Cancelled Pre Market | Sandoz Canada Inc. | Feb 2022 |
| SANDOZ METFORMIN XR (1000 MG) | 02479583 | Cancelled Pre Market | Sandoz Canada Inc. | Feb 2022 |
| SEGLUROMET (500 MG) | 02476215 | Cancelled Post Market | Merck Canada Inc | Feb 2021 |
| SEGLUROMET (1000 MG) | 02476223 | Cancelled Post Market | Merck Canada Inc | Feb 2021 |
| SEGLUROMET (500 MG) | 02476231 | Cancelled Post Market | Merck Canada Inc | Feb 2021 |
| SEGLUROMET (1000 MG) | 02476258 | Cancelled Post Market | Merck Canada Inc | Feb 2021 |
| TEVA-METFORMIN (500 MG) | 02045710 | Cancelled Post Market | Teva Canada Limited | May 2018 |
| TEVA-METFORMIN (850 MG) | 02230475 | Cancelled Post Market | Teva Canada Limited | May 2018 |
| VAN-METFORMIN (500 MG) | 02444933 | Cancelled Pre Market | Vanc Pharmaceuticals Inc | Jul 2019 |
| VAN-METFORMIN (850 MG) | 02444941 | Cancelled Pre Market | Vanc Pharmaceuticals Inc | Jul 2019 |